Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Immunol ; 191(12): 5951-8, 2013 Dec 15.
Article in English | MEDLINE | ID: mdl-24227779

ABSTRACT

B cell A disintegrin and metalloproteinase 10 (ADAM10) is required for the development and maintenance of proper secondary lymphoid tissue architecture; however, the underlying mechanism remains unclear. In this study, we show disturbances in naive lymph node architecture from B cell-specific ADAM10-deficient mice (ADAM10(B-/-)) including loss of B lymphocyte/T lymphocyte compartmentalization, attenuation of follicular dendritic cell reticula, excessive collagen deposition, and increased high endothelial venule formation. Because TNF-α signaling is critical for secondary lymphoid tissue architecture, we examined compensatory changes in ADAM17 and TNF-α in ADAM10(B-/-) B cells. Surprisingly, defective follicular development in these mice was associated with increased rather than decreased TNF-α expression. In this article, we describe an increase in TNF-α message, mRNA stability, soluble protein release, and membrane expression in ADAM10(B-/-) B cells compared with wild type (WT), which coincides with increased ADAM17 message and protein. To assess the mechanistic contribution of excessive TNF-α to abnormal lymphoid architecture in ADAM10(B-/-) mice, we performed a bone marrow reconstitution study. Rectification of WT architecture was noted only in irradiated WT mice reconstituted with ADAM10(B-/-) + TNF knockout bone marrow because of normalization of TNF-α levels not seen in ADAM10(B-/-) alone. We conclude that ADAM17 overcompensation causes excessive TNF-α shedding and further upregulation of TNF-α expression, creating an aberrant signaling environment within B cell cortical regions of ADAM10(B-/-) lymph nodes, highlighting a key interplay between B cell ADAM10 and ADAM17 with respect to TNF-α homeostasis.


Subject(s)
ADAM Proteins/physiology , Amyloid Precursor Protein Secretases/physiology , B-Lymphocytes/metabolism , Gene Expression Regulation/immunology , Germinal Center/ultrastructure , Lymph Nodes/ultrastructure , Membrane Proteins/physiology , Tumor Necrosis Factor-alpha/physiology , ADAM Proteins/biosynthesis , ADAM Proteins/deficiency , ADAM Proteins/genetics , ADAM10 Protein , ADAM17 Protein , Amyloid Precursor Protein Secretases/deficiency , Animals , Cells, Cultured , Dendritic Cells, Follicular/pathology , Female , Germinal Center/metabolism , Lymph Nodes/metabolism , Male , Membrane Proteins/deficiency , Mice , Mice, Congenic , Mice, Inbred C57BL , Mice, Knockout , RNA Stability/physiology , RNA, Messenger/metabolism , Radiation Chimera , Signal Transduction , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/genetics , Up-Regulation
2.
J Clin Microbiol ; 50(2): 469-71, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22116150

ABSTRACT

Among 23 patients carrying methicillin-resistant Staphylococcus aureus (MRSA) in their anterior nares, 6 (26%) also carried methicillin-susceptible S. aureus (MSSA) as less prevalent flora. In 4 of the 6 patients, the MSSA was unrelated to prevalent MRSA, as determined by pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and staphylococcal protein A (spa) typing. However, in two patients, the strains were identical except for the absence of spontaneous staphylococcal cassette chromosome mec (SCCmec). We consider this evidence of spontaneous SCCmec excision in vivo.


Subject(s)
Carrier State/microbiology , DNA, Bacterial/genetics , Gene Deletion , Methicillin Resistance , Nasal Mucosa/microbiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics , Chromosomes, Bacterial , Cluster Analysis , Electrophoresis, Gel, Pulsed-Field , Genotype , Humans , Microbial Sensitivity Tests , Molecular Typing , Staphylococcus aureus/classification , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification
3.
J Leukoc Biol ; 96(1): 151-9, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24610880

ABSTRACT

It has been shown recently that MCs are required for differential regulation of the immune response by granulocytic versus monocytic MDSCs. Granulocytic MDSCs promoted parasite clearance, whereas monocytic MDSCs enhanced tumor progression; both activities were abrogated in MC-deficient mice. Herein, we demonstrate that the lack of MCs also influences MDSC trafficking. Preferential trafficking to the liver was not seen in MC-deficient mice. In addition, evidence that the MC mediator histamine was important in MDSC trafficking and activation is also shown. MDSCs express HR1-3. Blockade of these receptors by HR1 or HR2 antagonists reversed the histamine enhancement of MDSC survival and proliferation observed in cell culture. In addition, histamine differentially influenced Arg1 and iNOS gene expression in MDSCs and greatly enhanced IL-4 and IL-13 message, especially in granulocytic MDSCs. Evidence that histamine influenced activity seen in vitro translated to in vivo when HR1 and HR2 antagonists blocked the effect of MDSCs on parasite expulsion and tumor metastasis. All of these data support the MDSC-mediated promotion of Th2 immunity, leading to the suggestion that allergic-prone individuals would have elevated MDSC levels. This was directly demonstrated by looking at the relative MDSC levels in allergic versus control patients. Monocytic MDSCs trended higher, whereas granulocytic MDSCs were increased significantly in allergic patients. Taken together, our studies indicate that MCs and MC-released histamine are critical for MDSC-mediated immune regulation, and this interaction should be taken into consideration for therapeutic interventions that target MDSCs.


Subject(s)
Histamine/immunology , Mast Cells/immunology , Receptors, Histamine/immunology , Animals , Cell Proliferation/drug effects , Cell Survival/drug effects , Cell Survival/genetics , Cell Survival/immunology , Histamine/genetics , Histamine Antagonists/pharmacology , Interleukin-13/genetics , Interleukin-13/immunology , Interleukin-4/genetics , Interleukin-4/immunology , Mice , Mice, Mutant Strains , Receptors, Histamine/genetics , Th2 Cells/immunology
SELECTION OF CITATIONS
SEARCH DETAIL